Transient hypoparathyroidism due to amphotericin B-induced hypomagnesemia in a patient with β-thalassemia

Annals of Pharmacotherapy

Volumn 35, Issue 9, 2001, Pages 1042-1044

  Marcus, N ^a   Garty, B Z ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Amphotericin B; Hypomagnesemia; Hypoparathyroidism; Thalassemia

Indexed keywords

AMPHOTERICIN B;

ADULT; ARTICLE; BETA THALASSEMIA; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CATHETER INFECTION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; HIGH RISK PATIENT; HOMEOSTASIS; HOSPITAL INFECTION; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; IRON STORAGE; KIDNEY DISEASE; MALE; PRIORITY JOURNAL;

EID: 0034829141     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10273     Document Type: Article

References (12)

1. Hypoparathyroidism in β-thalassemia major
2. Multicenter study on prevalence of endocrine complications in thalassemia major
3. Impaired parathyroid response to induced hypocalcemia in thalassemia major
4. Hormonal changes in thalassemia major
5. Combined vitamin D parathyroid defect in thalassemia major
6. The spectrum of parathyroid function in thalassemia subjects with transfusional iron overload
7. Hypomagnesemia: Renal magnesium handling
8. Hypomagnesemia-associated tetany due to intravenous administration of amphotericin B
9. Amphotericin B, aminoglycosides, and hypomagnesemic tetany
10. Amphotericin B nephrotoxicity
11. Renal magnesium wasting associated with amphotericin B therapy
12. A method for estimating the probability of adverse drug reactions